AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 53 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,010 | -100.0% | 942 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $36,281,260 | -30.8% | 2,363,600 | 0.0% | 0.09% | -37.2% |
| Q4 2022 | $52,448,284 | +29.6% | 2,363,600 | -4.6% | 0.14% | +21.8% |
| Q3 2022 | $40,466,000 | +12.5% | 2,478,000 | +0.1% | 0.12% | +21.4% |
| Q2 2022 | $35,954,000 | -21.3% | 2,474,500 | 0.0% | 0.10% | -4.9% |
| Q1 2022 | $45,704,000 | -22.3% | 2,474,500 | 0.0% | 0.10% | -5.5% |
| Q4 2021 | $58,819,000 | -3.5% | 2,474,500 | -0.1% | 0.11% | -6.0% |
| Q3 2021 | $60,981,000 | +25.2% | 2,475,900 | +25.6% | 0.12% | +27.5% |
| Q2 2021 | $48,701,000 | +24.0% | 1,970,916 | +9.5% | 0.09% | +19.7% |
| Q1 2021 | $39,267,000 | +7.5% | 1,800,434 | +25.8% | 0.08% | +1.3% |
| Q4 2020 | $36,534,000 | +1.9% | 1,431,600 | +12.4% | 0.08% | -10.7% |
| Q3 2020 | $35,852,000 | +242.0% | 1,273,600 | +243.4% | 0.08% | +223.1% |
| Q2 2020 | $10,482,000 | – | 370,919 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |